Molecular targets of lithium action.

Lithium is highly effective in the treatment of bipolar disorder and also has multiple effects on embryonic development, glycogen synthesis, hematopoiesis, and other processes. However, the mechanism of lithium action is still unclear. A number of enzymes have been proposed as potential targets of lithium action, including inositol monophosphatase, a family of structurally related phosphomonoesterases, and the protein kinase glycogen synthase kinase-3. These potential targets are widely expressed, require metal ions for catalysis, and are generally inhibited by lithium in an uncompetitive manner, most likely by displacing a divalent cation. Thus, the challenge is to determine which target, if any, is responsible for a given response to lithium in cells. Comparison of lithium effects with genetic disruption of putative target molecules has helped to validate these targets, and the use of alternative inhibitors of a given target can also lend strong support for or against a proposed mechanism of lithium action. In this review, lithium sensitive enzymes are discussed, and a number of criteria are proposed to evaluate which of these enzymes are involved in the response to lithium in a given setting.

[1]  D. Pollen,et al.  Cloning of a gene bearing missense mutations in early-onset familial Alzheimer's disease , 1995, Nature.

[2]  M. Weissman,et al.  Cross-national epidemiology of major depression and bipolar disorder. , 1996, JAMA.

[3]  G. Drewes,et al.  Glycogen synthase kinase‐3 and the Alzheimer‐like state of microtubule‐associated protein tau , 1992, FEBS letters.

[4]  J. York,et al.  Cloning and Characterization of a Mammalian Lithium-sensitive Bisphosphate 3′-Nucleotidase Inhibited by Inositol 1,4-Bisphosphate* , 1999, The Journal of Biological Chemistry.

[5]  Y. Masui,et al.  Lithium-induced respecification of pattern in Xenopus laevis embryos , 1986, Nature.

[6]  Michael J. Berridge,et al.  Neural and developmental actions of lithium: A unifying hypothesis , 1989, Cell.

[7]  D. Grunwald,et al.  Lithium perturbation and goosecoid expression identify a dorsal specification pathway in the pregastrula zebrafish. , 1993, Development.

[8]  M. Bourin,et al.  The effect of lithium administration in animal models of depression: a short review , 1999, Fundamental & clinical pharmacology.

[9]  B. Livingston,et al.  Lithium evokes expression of vegetal-specific molecules in the animal blastomeres of sea urchin embryos. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[10]  I. Jones,et al.  Genetics of bipolar disorder , 1999, Journal of medical genetics.

[11]  D. Chuang,et al.  Chronic lithium treatment robustly protects neurons in the central nervous system against excitotoxicity by inhibiting N-methyl-D-aspartate receptor-mediated calcium influx. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[12]  F. McCormick,et al.  Wnt Signaling to β-Catenin Involves Two Interactive Components , 2000, The Journal of Biological Chemistry.

[13]  L. Greene,et al.  Lithium ion inhibits nerve growth factor-induced neurite outgrowth and phosphorylation of nerve growth factor-modulated microtubule-associated proteins , 1985, The Journal of cell biology.

[14]  P. S. Klein,et al.  Activation of the Wnt signaling pathway: a molecular mechanism for lithium action. , 1997, Developmental biology.

[15]  N. Perrimon,et al.  Drosophila wingless: A paradigm for the function and mechanism of Wnt signaling , 1994, BioEssays : news and reviews in molecular, cellular and developmental biology.

[16]  P. Majerus,et al.  Properties of inositol polyphosphate 1-phosphatase. , 1988, The Journal of biological chemistry.

[17]  T. Dale,et al.  Interaction of Axin and Dvl‐2 proteins regulates Dvl‐2‐stimulated TCF‐dependent transcription , 1999, The EMBO journal.

[18]  J. Woodgett,et al.  Glycogen synthase kinase-3: functions in oncogenesis and development. , 1992, Biochimica et biophysica acta.

[19]  H. Manji,et al.  The Mood‐Stabilizing Agent Valproate Inhibits the Activity of Glycogen Synthase Kinase‐3 , 2000, Journal of neurochemistry.

[20]  Wei Hsu,et al.  The Mouse Fused Locus Encodes Axin, an Inhibitor of the Wnt Signaling Pathway That Regulates Embryonic Axis Formation , 1997, Cell.

[21]  J. Woodgett,et al.  Requirement for glycogen synthase kinase-3β in cell survival and NF-κB activation , 2000, Nature.

[22]  T. Dale,et al.  An assay for glycogen synthase kinase 3 (GSK-3) for use in crude cell extracts. , 1998, Analytical biochemistry.

[23]  Akira Kikuchi,et al.  Axil, a Member of the Axin Family, Interacts with Both Glycogen Synthase Kinase 3β and β-Catenin and Inhibits Axis Formation ofXenopus Embryos , 1998, Molecular and Cellular Biology.

[24]  P. Polakis Wnt signaling and cancer. , 2000, Genes & development.

[25]  G. Schellenberg,et al.  Candidate gene for the chromosome 1 familial Alzheimer's disease locus , 1995, Science.

[26]  Akira Kikuchi,et al.  Axin, a negative regulator of the Wnt signaling pathway, forms a complex with GSK‐3β and β‐catenin and promotes GSK‐3β‐dependent phosphorylation of β‐catenin , 1998 .

[27]  J. Springer,et al.  Structural studies of metal binding by inositol monophosphatase: evidence for two-metal ion catalysis. , 1995, Biochemistry.

[28]  Kathleen E. Rankin,et al.  Regulation of Glycogen Synthase Kinase 3β and Downstream Wnt Signaling by Axin , 1999, Molecular and Cellular Biology.

[29]  O'Connell Ra Lithium carbonate: psychiatric indications and medical complications. , 1974 .

[30]  J. Woodgett,et al.  Wingless inactivates glycogen synthase kinase‐3 via an intracellular signalling pathway which involves a protein kinase C. , 1996, The EMBO journal.

[31]  A. Takashima,et al.  Direct association of presenilin‐1 with β‐catenin , 1998 .

[32]  G. McNeil,et al.  Synergistic induction of neurotensin gene transcription in PC12 cells parallels changes in AP-1 activity. , 1994, Brain research. Molecular brain research.

[33]  L. Price,et al.  Lithium in the treatment of mood disorders. , 1994, The New England journal of medicine.

[34]  G. Moore,et al.  Regulation of signal transduction pathways and gene expression by mood stabilizers and antidepressants. , 1999, Psychosomatic medicine.

[35]  Simon Lovestone,et al.  Alzheimer's disease-like phosphorylation of the microtubule-associated protein tau by glycogen synthase kinase-3 in transfected mammalian cells , 1994, Current Biology.

[36]  C. DiLullo,et al.  Lithium Chloride Inhibits the Phosphorylation of Newly Synthesized Neurofilament Protein, NF‐M, in Cultured Chick Sensory Neurons , 1991, Journal of neurochemistry.

[37]  H. Manji,et al.  Signal transduction pathways. Molecular targets for lithium's actions. , 1995, Archives of general psychiatry.

[38]  D. Garrod,et al.  Induction of early stages of kidney tubule differentiation by lithium ions. , 1995, Developmental biology.

[39]  P. Roach,et al.  New Insights Into the Role and Mechanism of Glycogen Synthase Activation by Insulin , 1997, Diabetes.

[40]  G. Mayr,et al.  Role of phospholipase C in Dictyostelium: formation of inositol 1,4,5‐trisphosphate and normal development in cells lacking phospholipase C activity. , 1994, The EMBO journal.

[41]  T. Austin,et al.  A role for the Wnt gene family in hematopoiesis: expansion of multilineage progenitor cells. , 1997, Blood.

[42]  D. M. Ferkey,et al.  GBP, an Inhibitor of GSK-3, Is Implicated in Xenopus Development and Oncogenesis , 1998, Cell.

[43]  R. Papke,et al.  Neurobiology of lithium: an update. , 1998, The Journal of clinical psychiatry.

[44]  V. Villeret,et al.  Crystallographic evidence for the action of potassium, thallium, and lithium ions on fructose-1,6-bisphosphatase. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[45]  N. Freimer,et al.  Assessing the feasibility of linkage disequilibrium methods for mapping complex traits: an initial screen for bipolar disorder loci on chromosome 18. , 1999, American journal of human genetics.

[46]  T. Blundell,et al.  X-ray structure of yeast Hal2p, a major target of lithium and sodium toxicity, and identification of framework interactions determining cation sensitivity. , 2000, Journal of molecular biology.

[47]  F. Bosch,et al.  Lithium restores glycogen synthesis from glucose in hepatocytes from diabetic rats. , 1993, Archives of biochemistry and biophysics.

[48]  J. Ávila,et al.  Glycogen synthase kinase 3 phosphorylates recombinant human tau protein at serine‐262 in the presence of heparin (or tubulin) , 1995, FEBS letters.

[49]  B. Gumbiner,et al.  A Cell-Free Assay System for β-Catenin Signaling That Recapitulates Direct Inductive Events in the Early Xenopus laevis Embryo , 1999, The Journal of cell biology.

[50]  T. Akiyama,et al.  Axin, an inhibitor of the Wnt signalling pathway, interacts with β‐catenin, GSK‐3β and APC and reduces the β‐catenin level , 1998, Genes to cells : devoted to molecular & cellular mechanisms.

[51]  A. Hall,et al.  Axonal Remodeling and Synaptic Differentiation in the Cerebellum Is Regulated by WNT-7a Signaling , 2000, Cell.

[52]  D. Cox,et al.  Mode of proviral activation of a putative mammary oncogene (int-1) on mouse chromosome 15 , 1984, Nature.

[53]  P. Davies,et al.  A preparation of Alzheimer paired helical filaments that displays distinct tau proteins by polyacrylamide gel electrophoresis. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[54]  W. Klein,et al.  β-Catenin is essential for patterning the maternally specified animal-vegetal axis in the sea urchin embryo , 1998 .

[55]  H. Strutt,et al.  Glycogen synthase kinase 3 regulates cell fate in dictyostelium , 1995, Cell.

[56]  I. Dominguez,et al.  Role of glycogen synthase kinase 3 beta as a negative regulator of dorsoventral axis formation in Xenopus embryos. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[57]  H. Manji,et al.  Lithium Activates the c‐Jun NH2‐Terminal Kinases In Vitro and in the CNS In Vivo , 1999, Journal of neurochemistry.

[58]  F. Stockdale,et al.  Initiation of DNA synthesis in mammary epithelium and mammary tumors by lithium ions , 1980, Journal of cellular physiology.

[59]  J. Rommens,et al.  Presenilins Interact with Armadillo Proteins Including Neural‐Specific Plakophilin‐Related Protein and β‐Catenin , 1999, Journal of neurochemistry.

[60]  P. Sirota,et al.  Increased number of peripheral blood CD34+ cells in lithium‐treated patients , 1998, British journal of haematology.

[61]  P. Fraser,et al.  The Presenilin 1 Protein Is a Component of a High Molecular Weight Intracellular Complex That Contains β-Catenin* , 1998, The Journal of Biological Chemistry.

[62]  R. Roos,et al.  The role of β-catenin stability in mutant PS1-associated apoptosis , 1999 .

[63]  K. Kidd,et al.  Re-evaluation of the linkage relationship between chromosome 11p loci and the gene for bipolar affective disorder in the Old Order Amish , 1989, Nature.

[64]  N. Freimer,et al.  Understanding the genetic basis of mood disorders: where do we stand? , 1997, American journal of human genetics.

[65]  Y. Surdin-Kerjan,et al.  Salt tolerance and methionine biosynthesis in Saccharomyces cerevisiae involve a putative phosphatase gene. , 1993, The EMBO journal.

[66]  J. Jefferson,et al.  Prethymoleptic use of lithium. , 1999, The American journal of psychiatry.

[67]  A. Brown,et al.  Induction of kidney epithelial morphogenesis by cells expressing Wnt-1. , 1994, Developmental biology.

[68]  J. Woodgett,et al.  Regulation of the Protein Kinase Activity of ShaggyZeste-white3 by Components of the Wingless Pathway in Drosophila Cells and Embryos* , 1999, The Journal of Biological Chemistry.

[69]  L. Singh,et al.  The effects of glucose and the hexosamine biosynthesis pathway on glycogen synthase kinase-3 and other protein kinases that regulate glycogen synthase activity. , 2000, Journal of investigative medicine : the official publication of the American Federation for Clinical Research.

[70]  T. Robak,et al.  The effect of lithium chloride on granulocyte-macrophage progenitor cells (CFU-GM) and clonogenic leukaemic blasts (CFU-L) in the cultures in vitro. , 1991, Archivum immunologiae et therapiae experimentalis.

[71]  R. Stein,et al.  Lithium carbonate attenuation of chemotherapy-induced neutropenia. , 1977, The New England journal of medicine.

[72]  A. Harwood,et al.  Lithium therapy and signal transduction. , 2000, Trends in pharmacological sciences.

[73]  James R. Woodgett,et al.  Lithium inhibits glycogen synthase kinase-3 activity and mimics Wingless signalling in intact cells , 1996, Current Biology.

[74]  R. Goold,et al.  Inhibition of GSK-3beta leading to the loss of phosphorylated MAP-1B is an early event in axonal remodelling induced by WNT-7a or lithium. , 1998, Journal of cell science.

[75]  J. Woodgett,et al.  Molecular cloning and expression of glycogen synthase kinase‐3/factor A. , 1990, The EMBO journal.

[76]  R. Belmaker,et al.  Lithium inhibits adrenergic and cholinergic increases in GTP binding in rat cortex , 1988, Nature.

[77]  A. Coppen,et al.  Lithium in unipolar depression and the prevention of suicide. , 2000, The Journal of clinical psychiatry.

[78]  L. Williams,et al.  Bridging of β-catenin and glycogen synthase kinase-3β by Axin and inhibition of β-catenin-mediated transcription , 1998 .

[79]  H. Manji,et al.  Signalling pathways in the brain: cellular transduction of mood stabilisation in the treatment of manic-depressive illness. , 1999, The Australian and New Zealand journal of psychiatry.

[80]  P. Simpson,et al.  An early embryonic product of the gene shaggy encodes a serine/threonine protein kinase related to the CDC28/cdc2+ subfamily. , 1990, The EMBO journal.

[81]  Paul Polakis,et al.  Downregulation of β-catenin by human Axin and its association with the APC tumor suppressor, β-catenin and GSK3β , 1998, Current Biology.

[82]  P. V. van Haastert,et al.  Dictyostelium discoideum contains three inositol monophosphatase activities with different substrate specificities and sensitivities to lithium. , 1996, The Biochemical journal.

[83]  R A Roth,et al.  The Role of Glycogen Synthase Kinase 3β in Insulin-stimulated Glucose Metabolism* , 1999, The Journal of Biological Chemistry.

[84]  R. Lenox,et al.  Lithium and the brain: a psychopharmacological strategy to a molecular basis for manic depressive illness. , 1994, Clinical chemistry.

[85]  J. Morissette,et al.  Genome-wide search for linkage of bipolar affective disorders in a very large pedigree derived from a homogeneous population in quebec points to a locus of major effect on chromosome 12q23-q24. , 1999, American journal of medical genetics.

[86]  R. Serrano,et al.  A salt-sensitive 3'(2'),5'-bisphosphate nucleotidase involved in sulfate activation , 1995, Science.

[87]  Dresden,et al.  Die Lithiumprophylaxe der Depression vor 100 Jahren - ein genialer Irrtum* , 1987 .

[88]  W. Fiers,et al.  Lithium chloride potentiates tumor necrosis factor-mediated cytotoxicity in vitro and in vivo. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[89]  D. McClay,et al.  Nuclear beta-catenin is required to specify vegetal cell fates in the sea urchin embryo. , 1999, Development.

[90]  R. Lenox,et al.  Overview of the mechanism of action of lithium in the brain: fifty-year update. , 2000, The Journal of clinical psychiatry.

[91]  G. Rosen,et al.  The effect of lithium carbonate on leukopenia after chemotherapy. , 1980, The Journal of pediatrics.

[92]  P. Cohen,et al.  A GSK3‐binding peptide from FRAT1 selectively inhibits the GSK3‐catalysed phosphorylation of Axin and β‐catenin , 1999, FEBS letters.

[93]  Randall T Moon,et al.  Mechanism and function of signal transduction by the Wnt/β-catenin and Wnt/Ca2+ pathways , 1999, Oncogene.

[94]  D. Selkoe,et al.  Notch and presenilins in vertebrates and invertebrates: implications for neuronal development and degeneration , 2000, Current Opinion in Neurobiology.

[95]  P. L. Rodriguez,et al.  A Novel Mammalian Lithium-sensitive Enzyme with a Dual Enzymatic Activity, 3′-Phosphoadenosine 5′-Phosphate Phosphatase and Inositol-polyphosphate 1-Phosphatase* , 1999, The Journal of Biological Chemistry.

[96]  D. M. Ferkey,et al.  Interaction among Gsk-3, Gbp, Axin, and APC in Xenopus Axis Specification , 2000, The Journal of cell biology.

[97]  R. Nusse,et al.  Mechanisms of Wnt signaling in development. , 1998, Annual review of cell and developmental biology.

[98]  A. McMahon,et al.  Wnt-4 is a mesenchymal signal for epithelial transformation of metanephric mesenchyme in the developing kidney. , 1998, Development.

[99]  S. Gershon,et al.  Lithium and leukocytosis , 1971, Clinical pharmacology and therapeutics.

[100]  R. Nusse,et al.  A Versatile Transcriptional Effector of Wingless Signaling , 1997, Cell.

[101]  J. Ponder,et al.  Definition of a metal-dependent/Li(+)-inhibited phosphomonoesterase protein family based upon a conserved three-dimensional core structure. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[102]  M. Mercken,et al.  Presenilin 1 associates with glycogen synthase kinase-3beta and its substrate tau. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[103]  D. Melton,et al.  A molecular mechanism for the effect of lithium on development. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[104]  Norbert Perrimon,et al.  Putative protein kinase product of the Drosophila segment-polarity gene zeste-white3 , 1990, Nature.

[105]  J. Ávila,et al.  Lithium inhibits Alzheimer's disease‐like tau protein phosphorylation in neurons , 1997, FEBS letters.

[106]  D. J. Van Den Berg,et al.  Role of members of the Wnt gene family in human hematopoiesis. , 1998, Blood.

[107]  T. Kuno,et al.  Tol1, a Fission Yeast Phosphomonoesterase, Is an In Vivo Target of Lithium, and Its Deletion Leads to Sulfite Auxotrophy , 2000, Journal of bacteriology.

[108]  D. Peters,et al.  Lithium respecifies cyclic AMP-induced cell-type specific gene expression in Dictyostelium. , 1988, Developmental genetics.

[109]  Joyce Ra,et al.  The hematopoietic effects of lithium. , 1983 .

[110]  J. Baraban Toward a crystal-clear view of lithium's site of action. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[111]  H. Manji,et al.  Lithium stimulates gene expression through the AP-1 transcription factor pathway. , 1998, Brain research. Molecular brain research.

[112]  K. Imahori,et al.  Tau protein kinase I converts normal tau protein into A68-like component of paired helical filaments. , 1992, The Journal of biological chemistry.

[113]  S. Sokol,et al.  Axis determination in Xenopus involves biochemical interactions of axin, glycogen synthase kinase 3 and β-catenin , 1998, Current Biology.

[114]  R. Moon,et al.  Signal transduction through beta-catenin and specification of cell fate during embryogenesis. , 1996, Genes & development.

[115]  W. Sherman,et al.  The Effects of Lithium on myo‐Inositol Levels in Layers of Frontal Cerebral Cortex, in Cerebellum, and in Corpus Callosum of the Rat , 1980, Journal of neurochemistry.

[116]  J. Woodgett,et al.  Glycogen synthase kinase-3 induces Alzheimer's disease-like phosphorylation of tau: Generation of paired helical filament epitopes and neuronal localisation of the kinase , 1992, Neuroscience Letters.

[117]  Andrew P. McMahon,et al.  Ectopic expression of the proto-oncogene int-1 in Xenopus embryos leads to duplication of the embryonic axis , 1989, Cell.

[118]  R. Rozmahel,et al.  Presenilin mutations associated with Alzheimer disease cause defective intracellular trafficking of β-catenin,a component of the presenilin protein complex , 1999, Nature Medicine.

[119]  P. Quesenberry,et al.  Lithium stimulation of murine hematopoiesis in liquid culture: an effect mediated by marrow stromal cells. , 1984, Blood.

[120]  C. Larabell,et al.  Establishment of the Dorso-ventral Axis in Xenopus Embryos Is Presaged by Early Asymmetries in β-Catenin That Are Modulated by the Wnt Signaling Pathway , 1997, The Journal of cell biology.

[121]  G. Lyman,et al.  Lithium carbonate in patients with small cell lung cancer receiving combination chemotherapy. , 1981, The American journal of medicine.

[122]  R. Nusse,et al.  Wnt signaling: a common theme in animal development. , 1997, Genes & development.

[123]  M. Peifer,et al.  Wnt signaling in oncogenesis and embryogenesis--a look outside the nucleus. , 2000, Science.

[124]  A. Stoll,et al.  Mood Stabilizers: Shared Mechanisms of Action at Postsynaptic Signal‐Transduction and Kindling Processes , 1996, Harvard review of psychiatry.

[125]  A. Rodríguez-Navarro,et al.  The SAL1 gene of Arabidopsis, encoding an enzyme with 3'(2'),5'-bisphosphate nucleotidase and inositol polyphosphate 1-phosphatase activities, increases salt tolerance in yeast. , 1996, The Plant cell.

[126]  R. Stein,et al.  Lithium and granulocytopenia during induction therapy of acute myelogenous leukemia: update of an ongoing trial. , 1980, Advances in experimental medicine and biology.

[127]  M. Takahashi,et al.  Lithium Inhibits Neurite Growth and Tau Protein Kinase I/Glycogen Synthase Kinase‐3β‐Dependent Phosphorylation of Juvenile Tau in Cultured Hippocampal Neurons , 1999, Journal of neurochemistry.

[128]  Hans Clevers,et al.  Destabilization of β-catenin by mutations in presenilin-1 potentiates neuronal apoptosis , 1998, Nature.

[129]  H. Steinbeisser,et al.  β-catenin translocation into nuclei demarcates the dorsalizing centers in frog and fish embryos , 1996, Mechanisms of Development.

[130]  P. Salinas,et al.  WNT-7a induces axonal remodeling and increases synapsin I levels in cerebellar neurons. , 1997, Developmental biology.

[131]  Salinas Pc Wnt factors in axonal remodelling and synaptogenesis. , 1999 .

[132]  H. Pétursson,et al.  Molecular genetic evidence for heterogeneity in manic depression , 1987, Nature.

[133]  E. Nestler,et al.  Regulation of Endogenous ADP‐Ribosylation by Acute and Chronic Lithium in Rat Brain , 1995, Journal of neurochemistry.

[134]  A. Kikuchi,et al.  Modulation of Wnt signaling by Axin and Axil. , 1999, Cytokine & growth factor reviews.

[135]  D. Tollervey,et al.  Lithium toxicity in yeast is due to the inhibition of RNA processing enzymes , 1997, The EMBO journal.

[136]  M. Frosch,et al.  Presenilin 1 Facilitates the Constitutive Turnover of β-Catenin: Differential Activity of Alzheimer’s Disease–Linked PS1 Mutants in the β-Catenin–Signaling Pathway , 1999, The Journal of Neuroscience.

[137]  I. Rogers,et al.  LiCl disrupts axial development in mouse but does not act through the β‐catenin/Lef‐1 pathway , 2000, Molecular reproduction and development.

[138]  J. Trojanowski,et al.  A68: a major subunit of paired helical filaments and derivatized forms of normal Tau. , 1991, Science.

[139]  L. Goodman,et al.  The Pharmacological Basis of Therapeutics , 1941 .

[140]  J. Cade Lithium salts in the treatment of psychotic excitement. , 1949, The Medical journal of Australia.

[141]  N. Cairns,et al.  Tau proteins of alzheimer paired helical filaments: Abnormal phosphorylation of all six brain isoforms , 1992, Neuron.

[142]  W. Busa,et al.  Lithium-sensitive production of inositol phosphates during amphibian embryonic mesoderm induction. , 1992, Science.

[143]  J. Acharya,et al.  Synaptic Defects and Compensatory Regulation of Inositol Metabolism in Inositol Polyphosphate 1-Phosphatase Mutants , 1998, Neuron.

[144]  W. Sherman,et al.  The effects of lithium ion and other agents on the activity of myo-inositol-1-phosphatase from bovine brain. , 1980, The Journal of biological chemistry.

[145]  N. Freimer,et al.  Mapping genes for psychiatric disorders and behavioral traits. , 1995, Current opinion in genetics & development.

[146]  D. Chuang,et al.  Lithium protects rat cerebellar granule cells against apoptosis induced by anticonvulsants, phenytoin and carbamazepine. , 1998, The Journal of pharmacology and experimental therapeutics.

[147]  M. Lovett,et al.  Presenilin 1 interaction in the brain with a novel member of the Armadillo family , 1997, Neuroreport.

[148]  M. Kirschner,et al.  Control of beta-catenin stability: reconstitution of the cytoplasmic steps of the wnt pathway in Xenopus egg extracts. , 2000, Molecular cell.

[149]  Y. Maeda,et al.  INFLUENCE OF IONIC CONDITIONS ON CELL DIFFERENTIATION AND MORPHOGENESIS OF THE CELLULAR SLIME MOLDS , 1970, Development, growth & differentiation.

[150]  W. Busa,et al.  Lithium-induced teratogenesis in frog embryos prevented by a polyphosphoinositide cycle intermediate or a diacylglycerol analog. , 1989, Developmental biology.

[151]  A Aitken,et al.  Separation and characterisation of glycogen synthase kinase 3, glycogen synthase kinase 4 and glycogen synthase kinase 5 from rabbit skeletal muscle. , 1982, European journal of biochemistry.

[152]  John Q. Trojanowski,et al.  Abnormal tau phosphorylation at Ser396 in alzheimer's disease recapitulates development and contributes to reduced microtubule binding , 1993, Neuron.

[153]  F. Bosch,et al.  Effects of lithium ions on glycogen synthase and phosphorylase in rat hepatocytes. , 1986, The Journal of biological chemistry.

[154]  P. L. Rodriguez,et al.  A novel target of lithium therapy , 2000, FEBS letters.

[155]  J. Atack,et al.  In Vitro and In Vivo Inhibition of Inositol Monophosphatase by the Bisphosphonate L‐690,330 , 1993, Journal of neurochemistry.

[156]  K. Kao,et al.  Dorsalization of mesoderm induction by lithium. , 1989, Developmental biology.

[157]  A. Amdisen,et al.  The First Era of Lithium in Medicine An Historical Note* , 1983, Pharmacopsychiatria.

[158]  E. Wieschaus,et al.  Spatial expression of the Drosophila segment polarity gene armadillo is posttranscriptionally regulated by wingless , 1990, Cell.

[159]  T. Lepage,et al.  GSK3beta/shaggy mediates patterning along the animal-vegetal axis of the sea urchin embryo. , 1998, Development.

[160]  Michael J. Berridge,et al.  Inositol phosphates and cell signalling , 1989, Nature.

[161]  R. Jope,et al.  Lithium and brain signal transduction systems. , 1994, Biochemical pharmacology.

[162]  S. Kaech,et al.  Lithium reduces tau phosphorylation: effects in living cells and in neurons at therapeutic concentrations , 1999, Biological Psychiatry.

[163]  W. Birchmeier,et al.  Functional interaction of an axin homolog, conductin, with beta-catenin, APC, and GSK3beta. , 1998, Science.

[164]  W. Choi,et al.  Effects of lithium and insulin on glycogen synthesis in L6 myocytes: additive effects on inactivation of glycogen synthase kinase-3. , 2000, Biochimica et biophysica acta.

[165]  M. Goedert,et al.  Monoclonal antibody PHF‐1 recognizes tau protein phosphorylated at serine residues 396 and 404 , 1994, Journal of neuroscience research.

[166]  M. Deardorff,et al.  Xenopus axin interacts with glycogen synthase kinase-3 beta and is expressed in the anterior midbrain , 1999, Mechanisms of Development.

[167]  S. Pollack,et al.  Probing the role of metal ions in the mechanism of inositol monophosphatase by site-directed mutagenesis. , 1993, European journal of biochemistry.

[168]  Virginia M. Y. Lee,et al.  Lithium Reduces Tau Phosphorylation by Inhibition of Glycogen Synthase Kinase-3* , 1997, The Journal of Biological Chemistry.

[169]  N. Perrimon,et al.  wingless signaling acts through zeste-white 3, the drosophila homolog of glycogen synthase kinase-3, to regulate engrailed and establish cell fate , 1992, Cell.

[170]  S. Pierce,et al.  Regulation of Spemann organizer formation by the intracellular kinase Xgsk-3. , 1995, Development.

[171]  Harold E. Varmus,et al.  Glycogen synthase kinase-3 and dorsoventral patterning in Xenopus embryos , 1995, Nature.

[172]  M. Goedert,et al.  Glycogen synthase kinase-3β phosphorylates tau protein at multiple sites in intact cells , 1995, Neuroscience Letters.

[173]  P. Quesenberry,et al.  Lithium stimulation of HPP‐CFC and stromal growth factor production in murine dexter culture , 1992, Journal of cellular physiology.

[174]  T. Akiyama,et al.  Negative regulation of Wingless signaling by D-axin, a Drosophila homolog of axin. , 1999, Science.

[175]  F. S. Mathews,et al.  Crystal structure of inositol polyphosphate 1-phosphatase at 2.3-A resolution. , 1994, Biochemistry.

[176]  M. Czech Signal transmission by the insulin-like growth factors , 1989, Cell.

[177]  H. Clevers,et al.  T lymphocytes: differential role for glycogen , 2022 .

[178]  T. O'donohue,et al.  Lithium increases serotonin release and decreases serotonin receptors in the hippocampus. , 1981, Science.

[179]  B. Gumbiner,et al.  TCF is the nuclear effector of the beta-catenin signal that patterns the sea urchin animal-vegetal axis. , 2000, Developmental biology.

[180]  M. Roden,et al.  More marked stimulation by lithium than insulin of the glycogenic pathway in rat skeletal muscle. , 1997, The American journal of physiology.

[181]  J. Rommens,et al.  Familial Alzheimer's disease in kindreds with missense mutations in a gene on chromosome 1 related to the Alzheimer's disease type 3 gene , 1995, Nature.